CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate
  • How Immunotherapy Is Transforming Bladder Cancer Treatment

    Arjun V. Balar, MD, discusses checkpoint immunotherapy, new FDA approvals, promising new therapies, and clinical trials for…

    May 21, 2020| Arthur N. Brodsky, PhD
  • Immuno-Guided PET Scans May Improve Cancer Patient Treatment Decisions

    Dr. Kim Margolin highlights how novel medical imaging technologies may improve how doctors make treatment decisions with…

    May 20, 2020| Arthur N. Brodsky, PhD
  • The Role of Viperin in Viral Protection with Dr. Chun-Chieh ‘Jack’ Hsu

    CRI Fellow Dr. Chun-Chieh ‘Jack’ Hsu is exploring how the protein viperin helps protect us against viral…

    May 20, 2020| Arthur N. Brodsky, PhD
  • How COVID-19 is Impacting Care for Blood Cancer Patients

    CRI spoke with Dr. Melody Smith about how clinical care for leukemia, lymphoma, and multiple myeloma patients…

    May 8, 2020| Arthur N. Brodsky, PhD
  • How COVID-19 is Impacting Care for Lung Cancer Patients

    CRI spoke with Dr. Joshua Sabari about how clinical care for lung cancer patients has been impacted…

    May 7, 2020| Arthur N. Brodsky, PhD
  • Analytical Strategies in Immunology for Cancer and COVID-19 with Dr. Katie Campbell

    Dr. Campbell’s work as a CRI fellow at UCLA is improving our understanding of both cancer and…

    May 6, 2020| Arthur N. Brodsky, PhD
  • Cancer, COVID-19, and the Immune Genome with Dr. Brian Brown

    CRI Technology Impact Award recipient Dr. Brian Brown has been developing a technology to help us better…

    May 5, 2020| Arthur N. Brodsky, PhD
  • AACR20 Day 2 Highlights: COVID-19, Adoptive Cell Therapy, and Checkpoint Immunotherapy Insights

    The second day of AACR’s annual meeting heard from experts at cancer centers in COVID-19 hotspots around…

    April 29, 2020| Arthur N. Brodsky, PhD
  • AACR20 Day 1 Highlights: Breast Cancer, Lung Cancer, and the Microbiome

    The first day of the 2020 AACR Annual Meeting shared latest data from immunotherapy clinical trials in…

    April 28, 2020| Arthur N. Brodsky, PhD

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute